{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Salvia officinalis", "diabetes mellitus", "dyslipidemia", "statin"]], "OtherID": [], "CitationSubset": [], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27942500", "DateRevised": {"Year": "2020", "Month": "09", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "09", "Day": "03"}], "ELocationID": [], "Language": ["eng"], "Journal": {"ISSN": "2251-9637", "JournalIssue": {"Volume": "5", "Issue": "3", "PubDate": {"Year": "2016", "Season": "Summer"}}, "Title": "International journal of molecular and cellular medicine", "ISOAbbreviation": "Int J Mol Cell Med"}, "ArticleTitle": "Salvia officinalis (Sage) Leaf Extract as Add-on to Statin Therapy in Hypercholesterolemic Type 2 Diabetic Patients: a Randomized Clinical Trial.", "Pagination": {"StartPage": "141", "EndPage": "148", "MedlinePgn": "141-148"}, "Abstract": {"AbstractText": ["The efficacy and safety of <i>Salvia officinalis</i> combined with statin have not been evaluated in dyslipidemic diabetes mellitus type 2 (DDMT2) so far. The plant extract antioxidant activity was determined by the DPPH radical scavenging assay. The total flavonoid, total phenolic and quercetin contents of the capsules containing the plant extract were also measured. Moreover, the effects of 2-month extract intake (500 mg capsule three times a day) as add-on to daily use of 15 mg glyburide, 2000 mg metformin and 10 mg atorvastatin on the blood levels of fasting glucose (FG), 2 h postprandial glucose (2hPPG), glycosylated hemoglobin (HbA1c), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglyceride, high-density lipoprotein cholesterol (HDL-C), serum aspartate aminotransferase (AST), serum alanine aminotransferase (ALT), creatinine and body mass index were studied in 50 patients and compared with the placebo group (n=50).The extract IC<sub>50</sub> in the DPPH assay was 87.26\u00b10.003 \u00b5g/mL (mean\u00b1SD), whereas the ascorbic acid IC<sub>50</sub> was 5.626\u00b1 0.001 \u00b5g/mL (mean\u00b1SD). The total flavonoid, total phenolic and quercetin contents of the capsule containing the plant extract were 39.76\u00b13.58 mg of rutin equivalents (mean\u00b1SD), 30.33\u00b11.23 mg of gallic acid (mean\u00b1SD) and 0.13 mg, respectively. The extract lowered FG, 2hPPG, HbA1c, TC, LDL-C and triglyceride levels, but increased HDL-C level compared to the placebo at the endpoint (P<0.05). The extract did not affect the other parameters significantly and no adverse effect was reported. The extract has substantial antioxidant activity which may be beneficial for the prevention of the cardiovascular complications of DDMT2. Moreover, addition of the extract to statin therapy is apparently safe and further improves lipid profile."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}], "LastName": "Kianbakht", "ForeName": "Saeed", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}], "LastName": "Nabati", "ForeName": "Farzaneh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Diabetes Clinic, Karaj, Iran."}], "LastName": "Abasi", "ForeName": "Behrooz", "Initials": "B"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "Int J Mol Cell Med", "NlmUniqueID": "101598104", "ISSNLinking": "2251-9637"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Brietzke SA. Oral antihyperglycemic treatment options for type 2 diabetes mellitus. Med Clin North Am. 2015;99:87\u2013106.", "ArticleIdList": ["25456645"]}, {"Citation": "Taskinen MR, Boren J. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis. 2015;239:483\u201395.", "ArticleIdList": ["25706066"]}, {"Citation": "Frank ML, Gerhardt AM. Treating dyslipidemia in patients with type 2 diabetes mellitus. Nurse Pract. 2015;40:18\u201322. quiz -3.", "ArticleIdList": ["26164858"]}, {"Citation": "Halcox J, Misra A. Type 2 diabetes mellitus, metabolic syndrome, and mixed dyslipidemia: how similar, how different, and how to treat? Metab Syndr Relat Disord. 2015;13:1\u201321.", "ArticleIdList": ["25402738"]}, {"Citation": "Kones R, Rumana U. Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies. Drugs. 2015;75:1187\u201399.", "ArticleIdList": ["26115727"]}, {"Citation": "Kones R, Rumana U. Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs. Drugs. 2015;75:1201\u201328.", "ArticleIdList": ["26169307"]}, {"Citation": "Sando KR, Knight M. Nonstatin therapies for management of dyslipidemia: a review. Clin Ther. 2015;37:2153\u201379.", "ArticleIdList": ["26412799"]}, {"Citation": "Sikand G, Kris-Etherton P, Boulos NM. Impact of functional foods on prevention of cardiovascular disease and diabetes. Curr Cardiol Rep. 2015;17:39.", "ArticleIdList": ["25899657"]}, {"Citation": "Liu HJ, Zhang CY, Song F, et al. A novel partial agonist of peroxisome proliferator-activated receptor gamma with excellent effect on insulin resistance and type 2 diabetes. J Pharmacol Exp Ther. 2015;353:573\u201381.", "ArticleIdList": ["25876909"]}, {"Citation": "Fukuda K, Matsumura T, Senokuchi T, et al. Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-gamma activation. Biochem Biophys Res Commun. 2015;457:23\u201330.", "ArticleIdList": ["25529449"]}, {"Citation": "Fleming T. PDR for Herbal Medicines. 4th ed. . New York: Medical Economics Company; 2015."}, {"Citation": "Rau O, Wurglics M, Paulke A, et al. Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma. Planta Med. 2006;72:881\u20137.", "ArticleIdList": ["16858665"]}, {"Citation": "Christensen KB, Jorgensen M, Kotowska D, et al. Activation of the nuclear receptor PPARgamma by metabolites isolated from sage (Salvia officinalis L.) J Ethnopharmacol. 2010;132:127\u201333.", "ArticleIdList": ["20696231"]}, {"Citation": "Ninomiya K, Matsuda H, Shimoda H, et al. Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorg Med Chem Lett. 2004;14:1943\u20136.", "ArticleIdList": ["15050633"]}, {"Citation": "Moradabadi L, Montasser Kouhsari S, Fehresti Sani M. Hypoglycemic effects of three medicinal plants in experimental diabetes: inhibition of rat intestinal alpha-glucosidase and enhanced pancreatic insulin and cardiac Glut-4 mRNAs expression. Iran J Pharm Res. 2013;12:387\u201397.", "ArticleIdList": ["PMC3813273", "24250646"]}, {"Citation": "Oboh G, Henle T. Antioxidant and inhibitory effects of aqueous extracts of Salvia officinalis leaves on pro-oxidant-induced lipid peroxidation in brain and liver in vitro. J Med Food. 2009;12:77\u201384.", "ArticleIdList": ["19298199"]}, {"Citation": "Oniga I, Parvu AE, Toiu A, et al. Effects of Salvia officinalis L. extract on experimental acute inflammation. Rev Med Chir Soc Med Nat Iasi. 2007;111:290\u20134.", "ArticleIdList": ["17595884"]}, {"Citation": "Eidi M, Eidi A, Zamanizadeh H. Effect of Salvia officinalis L. leaves on serum glucose and insulin in healthy and streptozotocin-induced diabetic rats. J Ethnopharmacol. 2005;100:310\u20133.", "ArticleIdList": ["16125023"]}, {"Citation": "Lima CF, Azevedo MF, Araujo R, et al. Metformin-like effect of Salvia officinalis (common sage): is it useful in diabetes prevention? Br J Nutr. 2006;96:326\u201333.", "ArticleIdList": ["16923227"]}, {"Citation": "Sa CM, Ramos AA, Azevedo MF, et al. Sage tea drinking improves lipid profile and antioxidant defences in humans. Int J Mol Sci. 2009;10:3937\u201350.", "ArticleIdList": ["PMC2769154", "19865527"]}, {"Citation": "Kianbakht S, Abasi B, Perham M, et al. Antihyperlipidemic effects of Salvia officinalis L. leaf extract in patients with hyperlipidemia: a randomized double-blind placebo-controlled clinical trial. Phytother Res. 2011;25:1849\u201353.", "ArticleIdList": ["21506190"]}, {"Citation": "Kianbakht S, Dabaghian FH. Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L leaf extract: a randomized placebo Controlled clinical trial. Complement Ther Med. 2013;21:441\u20136.", "ArticleIdList": ["24050577"]}, {"Citation": "Behradmanesh S, Derees F, Rafieian-Kopaei M. Effect of Salvia officinalis on diabetic patients. J Renal Inj Prev. 2013;2:51\u20134.", "ArticleIdList": ["PMC4206016", "25340127"]}, {"Citation": "Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015;6:456\u201380.", "ArticleIdList": ["PMC4398902", "25897356"]}, {"Citation": "Han J, Weng X, Bi K. Antioxidants from a Chinese medicinal herb \u2013 Lithospermum erythrorhizon. Food Chemistry. 2008;106:2\u201310."}, {"Citation": "Gutfinger T. Polyphenols in olive oils. Journal of the American Oil Chemists Society. 1981;58:966\u20138."}, {"Citation": "Yoo KM, Lee CH, Lee H, et al. Relative antioxidant and cytoprotective activities of common herbs. Food Chemistry. 2008;106:929\u201336."}, {"Citation": "Verma N, Trehan N. HPLC analysis of methanolic extract of herbs for quercetin content. J Pharmacog Phytochem. 2013;2:159\u201362."}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "5", "Day": "10"}, {"Year": "2016", "Month": "8", "Day": "14"}, {"Year": "2016", "Month": "12", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "13", "Hour": "6", "Minute": "1"}, {"Year": "2016", "Month": "6", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27942500", "PMC5125366"]}}], "PubmedBookArticle": []}